Aligos Therapeutics Inc (ALGS)

13.04 -0.66  -4.82% NASDAQ Dec 3, 16:00 13.00 -0.04  -0.31% After-Hours: 20:00 USD

Aligos Therapeutics Debt to Equity Ratio:

0.00 for Sept. 30, 2021
View 4,000+ financial data types
View Full Chart

Debt to Equity Ratio Chart

Export Data
Save Image
Print Image

Historical Debt to Equity Ratio Data

View and export this data going back to 2021. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 0.00
June 30, 2021 0.00
March 31, 2021 0.00

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Benchmarks

CEL-SCI Corp --
AIM ImmunoTech Inc 0.00
NovaBay Pharmaceuticals Inc 0.00

Debt to Equity Ratio Range, Past 5 Years

Minimum 0.00 Mar 2021
Maximum 0.00 Mar 2021
Average 0.00

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly) 263.07M
Total Liabilities (Quarterly) 46.06M
Shareholders Equity (Quarterly) 217.01M
Current Ratio 7.150





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.